Vimarsana
Biggest News Aggregation in the World

China Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from China Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In China Phase Today - Breaking & Trending Today

Lilly Announces Details of Pirtobrutinib Presentations in B-Cell Malignancies at 2023 ASH Annual Meeting - Vimarsana News

Lilly Announces Details of Pirtobrutinib Presentations in B-Cell Malignancies at 2023 ASH Annual Meeting

/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that data from studies of pirtobrutinib, a non-covalent (reversible) Bruton's tyrosine kinase...

HUTCHMED Reports 2023 Interim Results and Provides Business Updates - HUTCHMED (China) (NASDAQ:HCM) - Vimarsana News

HUTCHMED Reports 2023 Interim Results and Provides Business Updates - HUTCHMED (China) (NASDAQ:HCM)

Strong execution on strategic direction, delivering near-term value while charting a path for growth, exemplified by global partnership with Takeda Revenue grew 164% (173% CER) to US$533 million, with net income to

HUTCHMED Reports 2023 Interim Results and Provides Business Updates - Vimarsana News

HUTCHMED Reports 2023 Interim Results and Provides Business Updates

Strong execution on strategic direction, delivering near-term value while charting a path for growth, exemplified by global partnership with Takeda Revenue grew 164% to US$533 million, with net...

Leverage technology to go global - Prof. Aryeetey charges UHAS graduates - Vimarsana News

Leverage technology to go global - Prof. Aryeetey charges UHAS graduates

Graduates from tertiary institutions in Ghana have been encouraged to think globally and take advantage of current opportunities in the world of work.

Terns Pharmaceuticals Announces Publication of TERN-701 Trial-in-Progress Abstract for the 2023 ASCO Annual Meeting - Vimarsana News

Terns Pharmaceuticals Announces Publication of TERN-701 Trial-in-Progress Abstract for the 2023 ASCO Annual Meeting

- Enrollment progress update from ongoing China Phase 1 trial of TERN-701 to be presented at ASCO 2023 - China Phase 1 trial completed enrollment of Cohort 5 in the Dose Escalation phase FOSTER... | May 25, 2023